Table 2.
Parameters | WBC group | KT group | P | |
---|---|---|---|---|
hsCRP (s) (mg/l) | Before | 13.5 ± 16.3 | 13.9 ± 15.2 | 0.942 |
After | 9.2 ± 15.3 | 13.6 ± 16.2 | 0.438 | |
∗ P | 0.002 | 0.623 | ||
Δ | −4.24 ± 5.68 | −0.27 ± 3.25 | 0.023 | |
| ||||
CER (s) (mg/dl) | Before | 62.83 ± 12.61 | 67.57 ± 12.60 | 0.296 |
After | 51.32 ± 10.74 | 53.51 ± 14.26 | 0.628 | |
∗ P | 0.006 | 0.003 | ||
Δ | −11.51 ± 16.6 | −14.06 ± 14.47 | 0.646 | |
| ||||
IL-6 (p) (pg/ml) | Before | 41.6 ± 8.86 | 41.8 ± 10.5 | 0.957 |
After | 36.6 ± 7.89 | 41.0 ± 10.4 | 0.191 | |
∗ P | 0.121 | 0.301 | 0.216 | |
Δ | −4.94 ± 11.9 | −0.74 ± 5.71 | ||
| ||||
sICAM-1 (p) (ng/ml) | Before | 79.0 ± 15.5 | 84.3 ± 21.9 | 0.432 |
After | 69.2 ± 14.2 | 83.9 ± 20.0 | 0.023 | |
∗ P | 0.088 | 0.642 | ||
Δ | −9.84 ± 23.0 | −0.41 ± 16.1 | 0.191 | |
| ||||
BASDAI | Before | 5.43 ± 1.61 | 5.28 ± 1.71 | 0.720 |
After | 3.29 ± 0.91 | 4.53 ± 1.62 | <0.05 | |
∗ P | <0.001 | <0.001 | ||
Δ | −2.14 ± 1.23 | −0.74 ± 0.38 | 0.001 | |
| ||||
BASFI | Before | 5.20 ± 2.29 | 5.01 ± 2.06 | 1.00 |
After | 3.81 ± 2.20 | 4.35 ± 2.23 | 0.497 | |
∗ P | <0.001 | <0.001 | ||
Δ | −1.39 ± 1.03 | −0.66 ± 0.39 | <0.01 |
P: statistical significance of differences between both groups of patients; ∗P: statistical significance of differences between values before and after treatment in particular groups of patients.